Report Description Table of Contents Intensity Modulated Radiotherapy Market: How Are Cancer Treatment Needs and Planning Technologies Shaping Investment? – (Updated On: 13th-Nov-2026) According to Strategic Market Research, the Global Intensity-Modulated Radiotherapy (IMRT) Market was estimated at USD 2.78 billion in 2025 and is projected to reach USD 4.41 billion by 2032, expanding at a CAGR of 6.81% during 2026–2032. IMRT is becoming an important cancer treatment as hospitals increasingly use advanced radiation technology to target tumors while reducing exposure to nearby healthy organs. Rising prostate and head and neck cancer cases, growing demand for precise radiation treatment, and the need to reduce treatment-related side effects are supporting market demand. Cancer centers are increasingly investing in advanced radiotherapy machines, computer-controlled radiation systems, and treatment-planning software to improve treatment accuracy and manage complex tumors. Prostate cancer is a major reason for the use of IMRT. According to the American Cancer Society, the United States is expected to record 333,830 new prostate cancer cases and 36,320 deaths in 2026. IMRT helps doctors target prostate tumors while reducing radiation exposure to nearby organs such as the bladder and rectum. A 2026 clinical study published in JAMA involving 698 patients reported that 92.1% of patients receiving IMRT were alive without disease progression at three years, compared with 88.6% receiving another radiation technique called SBRT. This shows that IMRT remains an important treatment option for prostate cancer, although the study does not prove that it is better for every patient. Head and neck cancers also create strong demand for IMRT. The American Cancer Society estimates 60,480 new mouth and throat cancer cases and 13,150 deaths in the United States in 2026. These cancers often develop close to important organs, making precise radiation treatment especially useful. A 2026 clinical study involving 98 patients found that 22.7% of IMRT patients experienced moderate or more severe mouth inflammation, compared with 7.4% receiving proton therapy. The study highlights the importance of improving radiation precision to reduce treatment-related side effects. Cancer hospitals are also investing in advanced radiation treatment technologies. A 2026 European radiotherapy survey covering 200 treatment centers reported 660 conventional radiation treatment machines and 101 ring-shaped machines. IMRT and a related technique called VMAT were among the most commonly used radiation methods at these centers. This demonstrates the importance of modern treatment machines and software that allow hospitals to deliver precise radiation therapy. Competition in the IMRT Market is increasing as companies develop better machines and software to make cancer radiation treatment more accurate and easier to plan. In May 2026, Siemens Healthineers (Varian) introduced an AI-based planning tool that can automatically identify more than 200 body structures in medical scans, helping doctors prepare treatment plans faster. In September 2026, Accuray and RaySearch partnered to make their treatment machines and planning software work together. Elekta also reported that its Unity radiation system had treated more than 15,000 patients across 17 Chinese hospitals. These developments highlight competition in accurate radiation delivery and improved cancer treatment planning. Analytical view: Rising prostate and head and neck cancer cases, the need to protect healthy organs, and the use of advanced radiation treatment machines are supporting the IMRT market. Hospitals and cancer centers represent important customers for IMRT-capable equipment, treatment-planning software, and technology upgrades. Which Leading and Emerging Segments Are Shaping the Intensity Modulated Radiotherapy Market? By Technique: Rotational Delivery Supports Treatment Efficiency and Organ Protection Leading and Fastest-Growing Segment: Volumetric Modulated Arc Therapy (VMAT) Volumetric Modulated Arc Therapy (VMAT) dominates the technique category of the Intensity Modulated Radiotherapy Market, accounting for an estimated 38% market share, valued at USD 1.056 billion in 2025. VMAT represents an advanced rotational form of Intensity Modulated Radiotherapy (IMRT), delivering precisely targeted radiation continuously as the linear accelerator rotates around the patient. Its ability to improve treatment efficiency, shorten treatment sessions, and minimize radiation exposure to surrounding healthy tissues supports its adoption. VMAT is projected to reach USD 1.883 billion by 2032, growing at a CAGR of 8.61%. By Product: LINAC Investment and Automated Planning Shape Treatment Capacity Leading Segment: Linear Accelerators Linear accelerators (LINACs) hold approximately 68% of the Intensity-Modulated Radiotherapy (IMRT) Market, valued at USD 1.890 billion in 2025, and are projected to reach USD 2.926 billion by 2032, growing at a CAGR of 6.44%. LINACs serve as the primary treatment delivery systems for IMRT, generating and precisely controlling high-energy X-ray or electron beams to target cancer cells while minimizing exposure to surrounding healthy tissue. Increasing adoption of precision radiotherapy, advanced beam modulation, and image-guided treatment capabilities supports their widespread clinical utilization. Fastest-Growing Segment: Treatment Planning Software Treatment Planning Software (TPS) serves as the core computational and clinical decision-support platform for Intensity Modulated Radiotherapy (IMRT), enabling precise radiation dose optimization, target volume delineation, and protection of surrounding healthy tissues. Treatment planning software accounted for an estimated 20% market share, valued at USD 556.0 million in 2025, and is projected to reach approximately USD 974 million by 2032, growing at a CAGR of 8.34%. Increasing adoption of automated planning, AI-assisted contouring, and advanced dose optimization is strengthening its role in personalized cancer treatment. By Application: Prostate Treatment Volumes and Complex Lung Tumors Sustain Demand Leading Segment: Prostate Cancer Prostate cancer represents the largest application within the Intensity Modulated Radiotherapy Market, accounting for approximately 28% of the market, valued at USD 778.4 million in 2025, and is projected to reach USD 1.195 billion by 2032, growing at a CAGR of 6.32%. Intensity Modulated Radiotherapy (IMRT) plays a critical curative role in treating localized and regional prostate cancer as an established external beam radiation therapy (EBRT) technique, enabling precise radiation delivery to cancerous tissues while minimizing exposure to surrounding healthy organs and supporting improved treatment outcomes. Fastest-Growing Segment: Lung Cancer Lung cancer accounts for approximately 23% of the global Intensity Modulated Radiotherapy Market, valued at USD 639.4 million in 2025, and is projected to reach USD 1.055 billion by 2032, growing at a CAGR of 7.42%. Intensity modulated radiotherapy plays a critical role in treating lung cancer, particularly locally advanced non-small cell lung cancer (NSCLC), by precisely shaping radiation beams to match the tumor’s three-dimensional contours while minimizing exposure to surrounding healthy lung tissue, the heart, and other critical organs. By End User: Hospital Infrastructure and Dedicated Cancer Programs Support Adoption Leading Segment: Hospitals Hospitals dominate the Intensity Modulated Radiotherapy (IMRT) Market, accounting for an estimated 58% share, valued at USD 1.612 billion in 2025, and are projected to reach USD 2.481 billion by 2032, growing at a CAGR of 6.35%. Hospitals maintain their leading position through advanced radiotherapy infrastructure, skilled radiation oncologists, medical physicists, and precision treatment-planning systems. Their ability to integrate IMRT with multidisciplinary cancer care, advanced imaging, and quality-assurance protocols supports accurate radiation delivery, improved treatment outcomes, and wider clinical adoption. Fastest-Growing Segment: Cancer Centers Cancer Centers play a central, multidisciplinary role in the planning, delivery, and quality assurance of intensity modulated radiotherapy (IMRT), integrating advanced treatment planning, precision dose optimization, image guidance, and coordinated oncology care. Dedicated cancer centers accounted for approximately 30% of the global Intensity Modulated Radiotherapy Market, valued at USD 834.0 million in 2025, and are projected to reach USD 1.406 billion by 2032, registering a CAGR of 7.75%. Increasing adoption of precision radiotherapy for complex tumors and organ-sparing treatments supports continued expansion. By Country: U.S. Treatment Modernization and Chinese Capacity Expansion Shape Demand Leading Country: United States The United States leads the global Intensity Modulated Radiotherapy Market, with an estimated valuation of USD 910 million in 2025, accounting for approximately 32.7% of the global market. The U.S. market is projected to reach USD 1.33 billion by 2032, expanding at a CAGR of 5.6%. Intensity-Modulated Radiation Therapy (IMRT) has evolved from a specialized treatment technique into a widely established standard of care across American oncology centers, supported by advanced radiotherapy infrastructure, widespread clinical adoption, and increasing utilization of precision radiation treatments for complex cancers. Fastest-Growing Country: China China's Intensity-Modulated Radiotherapy (IMRT) Market is estimated at approximately USD 310 million in 2025, accounting for 11.2% of the global market, and is projected to reach USD 635 million by 2032, growing at an indicative CAGR of 10.8%. China's radiotherapy landscape has evolved from conventional radiation techniques toward widespread clinical adoption of IMRT as a standard cancer treatment modality. Expanding oncology infrastructure, increasing installation of advanced linear accelerators, and greater access to precision radiation therapy across tertiary hospitals are supporting sustained market expansion. Which Companies Are Shaping the Competitive Landscape of the Intensity Modulated Radiotherapy Market? Siemens Healthineers (Varian): Integrated Imaging, Planning, and Radiation Delivery Strengthen Market Reach Siemens Healthineers, through its Varian oncology business, is a leading global provider of intensity-modulated radiotherapy technology, offering linear accelerators, treatment-planning software, image-guided treatment systems, and integrated radiation oncology solutions. Siemens Healthineers completed its acquisition of Varian in 2021 in a transaction valued at approximately USD 16.4 billion, significantly expanding its position across cancer diagnosis and treatment. Varian's TrueBeam, Halcyon, and Ethos platforms support advanced radiotherapy delivery, including IMRT and volumetric modulated arc therapy (VMAT), with Ethos emphasizing adaptive treatment workflows. Its Eclipse treatment-planning system supports complex radiation dose optimization and clinical workflow integration. The company's competitive position is supported by its established radiotherapy equipment portfolio, global service infrastructure, and ability to combine imaging, treatment planning, and radiation delivery. Within the USD 2.78 billion global IMRT market in 2025, Siemens Healthineers is positioned to participate in capital-equipment replacement, software upgrades, and investment in advanced oncology treatment capacity. Other Key Companies and Their Market Roles: Elekta AB: Competes in advanced radiotherapy equipment through its Versa HD and Harmony linear accelerator platforms, supporting IMRT, VMAT, and image-guided treatments. Koninklijke Philips N.V.: Supports IMRT workflows through its Pinnacle treatment-planning technology and oncology imaging solutions, emphasizing treatment planning and clinical integration. Hitachi, Ltd.: Has participated in radiotherapy equipment and oncology technology development, including particle therapy systems, with a more specialized position in radiation oncology infrastructure. Accuray Incorporated: Provides the Radixact platform, incorporating Tomotherapy technology for helical IMRT delivery and image-guided radiation treatment. Analyst Commentary: How Can Precision, Throughput, and Lifecycle Costs Shape Competitive Advantage? The Intensity Modulated Radiotherapy Market presents significant opportunities in VMAT adoption, AI-assisted treatment planning, adaptive radiotherapy, and linear accelerator modernization. Competitive advantage will increasingly depend on treatment precision, patient throughput, equipment utilization, and lifecycle costs. Manufacturers offering integrated radiation delivery, automated planning, and quality assurance solutions are well-positioned to capture hospital modernization investments and expand their presence in specialized cancer treatment centers. Intensity Modulated Radiotherapy Market Report Coverage Table Report Attribute Details Forecast Period 2026 – 2032 Market Size Value in 2025 USD 2.78 Billion Revenue Forecast in 2032 USD 4.41 Billion Overall Growth Rate CAGR of 6.81% (2026 – 2032) Base Year for Estimation 2025 Historical Data 2019 – 2024 Unit USD Million/Billion, CAGR (2026 – 2032) Segmentation By Technique, By Product, By Application, By End User, By Geography By Technique Volumetric Modulated Arc Therapy (VMAT), Sliding Window IMRT, Step-and-Shoot IMRT, Tomotherapy By Product Linear Accelerators, Treatment Planning Software, Quality Assurance (QA) Equipment By Application Prostate Cancer, Head and Neck Cancer, Lung Cancer, Breast Cancer By End User Hospitals, Cancer Centers, Radiotherapy Clinics By Region North America, Europe, Asia-Pacific, Latin America, Middle East & Africa Country Scope U.S., Canada, UK, Germany, France, Italy, China, Japan, South Korea, India, Brazil, Mexico, Saudi Arabia, UAE, South Africa Market Drivers Rising prostate and head and neck cancer cases, demand for precise radiation treatment and healthy tissue protection, investment in IMRT-capable equipment, treatment-planning software adoption and technology upgrades Customization Option Available upon request Frequently Asked Question About This Report Q1. What factors are driving growth across the Intensity Modulated Radiotherapy Market? A1. Growth is supported by rising prostate, lung, and head and neck cancer treatment volumes, increasing demand for precise radiation delivery, and hospital investment in advanced radiotherapy systems and planning software. Q2. Which IMRT technique holds the strongest market position? A2. Volumetric Modulated Arc Therapy (VMAT) leads with a 38% share, equivalent to USD 1.056 billion in 2025, and is projected to grow at a CAGR of 8.61% during 2026–2032. Q3. Which product category offers the strongest growth opportunity in the industry? A3. Treatment Planning Software is projected to record the fastest product CAGR of 8.34% during 2026–2032, supported by AI-assisted contouring, automated planning, and advanced dose optimization. Q4. Which cancer application is expected to expand the fastest? A4. Lung cancer is projected to record the fastest application CAGR of 7.42% during 2026–2032, supported by increasing use of precise radiation delivery for complex and locally advanced tumors. Q5. Which end-user segment is expected to grow the fastest? A5. Cancer centers are projected to record the fastest end-user CAGR of 7.75% during 2026–2032, supported by growing adoption of precision radiotherapy, image guidance, and multidisciplinary oncology treatment. Q6. Which region is expected to record the fastest growth in the market? A6. Asia-Pacific is projected to record the fastest regional CAGR of 8.81% during 2026–2032, supported by expanding oncology infrastructure, increasing radiotherapy capacity, and greater access to advanced treatment systems. Sources: U.S. National Cancer Institute – Reports an Estimated 333,830 New Prostate Cancer Cases and 36,320 Deaths in the United States in 2026 NCI SEER – Prostate Cancer Statistics and Treatment Population Context U.S. National Cancer Institute – Reports an Estimated 60,480 New Oral Cavity and Pharynx Cancer Cases and 13,150 Deaths in 2026 NCI SEER – Oral Cavity and Pharynx Cancer Statistics U.S. National Cancer Institute – Identifies IMRT as an External-Beam Radiation Technique That Varies Beam Intensity to Target Tumors While Limiting Exposure to Healthy Tissue NCI – External-Beam Radiation Therapy and IMRT Treatment Delivery Siemens Healthineers – Announced CE Marking for AI Contouring Integrated With Varian Eclipse on May 15, 2026, Supporting Automatic Contouring of More Than 200 Structures From CT and MR Images Siemens Healthineers – Eclipse AI Contouring: May 2026 Regulatory and Product Development Accuray and RaySearch – Announced an Expanded Collaboration on September 11, 2026, to Integrate RayStation With Accuray Platforms, Including an USD 8 Million Software License Commitment Accuray – RaySearch Partnership for Online Adaptive Radiation Therapy Accuray – Radixact Supports Image-Guided IMRT, With Treatment Planning Provided Through the Accuray Precision System Accuray – Radixact Radiation Delivery and Treatment-Planning Portfolio Elekta – Versa HD Supports VMAT Delivery and Treatment Planning for Complex Tumors, Including Lung and Prostate Applications Elekta – Versa HD Radiotherapy Platform and VMAT Capabilities Philips – Pinnacle Evolution Provides Personalized IMRT and VMAT Treatment-Planning Technology Philips – Pinnacle Evolution: IMRT and VMAT Treatment Planning Siemens Healthineers – Completed Its Acquisition of Varian on April 15, 2021, for USD 16.4 Billion, Expanding Its Radiation Oncology Business Siemens Healthineers – Annual Report 2021: Varian Acquisition Details Table of Contents - Global Intensity Modulated Radiotherapy Market Report (2026–2032) Executive Summary Market Overview Market Attractiveness by Technique, Product, Application, End User, and Region Strategic Insights from Key Executives (CXO Perspective) Historical Market Size and Volume (2019–2024) Base Year Market Size Analysis (2025) Market Size and Volume Forecasts (2026–2032) Summary of Market Segmentation by Technique, Product, Application, End User, and Region Market Share Analysis Leading Players by Revenue and Market Share Market Share Analysis by Technique, Product, Application, and End User Investment Opportunities in the Intensity Modulated Radiotherapy Market Key Developments and Innovations Mergers, Acquisitions, and Strategic Partnerships High-Growth Segments for Investment Opportunities in VMAT, Linear Accelerators, Treatment Planning Software, Quality Assurance Equipment, AI-Assisted Planning, and Advanced Radiation Delivery Market Introduction Definition and Scope of the Study Market Structure and Key Findings Overview of Top Investment Pockets Strategic Importance of IMRT in Prostate Cancer, Head and Neck Cancer, Lung Cancer, and Breast Cancer Treatment Role of Precision Radiation Delivery in Protecting Surrounding Healthy Organs Research Methodology Research Process Overview Primary and Secondary Research Approaches Market Size Estimation and Forecasting Techniques Data Triangulation and Segment-Level Forecasting Approach Market Dynamics Key Market Drivers Challenges and Restraints Impacting Growth Emerging Opportunities for Stakeholders Impact of Regulatory and Clinical Factors Role of Precision Radiation Treatment, Advanced Linear Accelerators, and Treatment-Planning Software in Market Expansion AI-Assisted Planning, Adaptive Radiotherapy, Treatment Accuracy, and Healthy-Organ Protection Trends Hospital Investment in Radiotherapy Equipment and Technology Upgrades Global Intensity Modulated Radiotherapy Market Analysis Historical Market Size and Volume (2019–2024) Base Year Market Size Analysis (2025) Market Size and Volume Forecasts (2026–2032) Market Analysis by Technique: Volumetric Modulated Arc Therapy (VMAT) Sliding Window IMRT Step-and-Shoot IMRT Tomotherapy Market Analysis by Product: Linear Accelerators Treatment Planning Software Quality Assurance (QA) Equipment Market Analysis by Application: Prostate Cancer Head and Neck Cancer Lung Cancer Breast Cancer Market Analysis by End User: Hospitals Cancer Centers Radiotherapy Clinics Market Analysis by Region: North America Europe Asia-Pacific Latin America Middle East & Africa Regional Market Analysis North America Intensity Modulated Radiotherapy Market Analysis Historical Market Size and Volume (2019–2024) Base Year Market Size Analysis (2025) Market Size and Volume Forecasts (2026–2032) Market Analysis by Technique, Product, Application, and End User Country-Level Breakdown: United States Canada Mexico Europe Intensity Modulated Radiotherapy Market Analysis Historical Market Size and Volume (2019–2024) Base Year Market Size Analysis (2025) Market Size and Volume Forecasts (2026–2032) Market Analysis by Technique, Product, Application, and End User Country-Level Breakdown: Germany France United Kingdom Italy Spain Rest of Europe Asia-Pacific Intensity Modulated Radiotherapy Market Analysis Historical Market Size and Volume (2019–2024) Base Year Market Size Analysis (2025) Market Size and Volume Forecasts (2026–2032) Market Analysis by Technique, Product, Application, and End User Country-Level Breakdown: China India Japan South Korea Australia Rest of Asia-Pacific Latin America Intensity Modulated Radiotherapy Market Analysis Historical Market Size and Volume (2019–2024) Base Year Market Size Analysis (2025) Market Size and Volume Forecasts (2026–2032) Market Analysis by Technique, Product, Application, and End User Country-Level Breakdown: Brazil Mexico Rest of Latin America Middle East & Africa Intensity Modulated Radiotherapy Market Analysis Historical Market Size and Volume (2019–2024) Base Year Market Size Analysis (2025) Market Size and Volume Forecasts (2026–2032) Market Analysis by Technique, Product, Application, and End User Country-Level Breakdown: Saudi Arabia United Arab Emirates South Africa Rest of Middle East & Africa Competitive Intelligence and Benchmarking Leading Key Players: Siemens Healthineers (Varian) Elekta AB Koninklijke Philips N.V. Hitachi, Ltd. Accuray Incorporated RaySearch Laboratories AB Brainlab SE ViewRay, Inc. Mevion Medical Systems Competitive Landscape and Strategic Insights Benchmarking Based on Radiation Delivery Systems, Treatment Planning Software, Image Guidance, and Quality Assurance Capabilities Linear Accelerator Portfolio Positioning VMAT and Tomotherapy Technology Competitiveness AI-Assisted Treatment Planning and Automated Contouring Strategy Analysis Strategic Partnerships and Technology Integration Equipment Modernization and Oncology Center Expansion Strategies Appendix Abbreviations and Terminologies Used in the Report References and Sources Market Definitions and Scope Segmentation Definitions and Classification Historical Data Coverage (2019–2024) Base Year Definitions and Assumptions (2025) Forecast Methodology and Assumptions (2026–2032) List of Tables Market Size by Technique, Product, Application, End User, and Region (2026–2032) Historical Market Size and Volume (2019–2024), Base Year Market Size Analysis (2025), and Forecasts (2026–2032) Regional Market Breakdown by Segment Type (2026–2032) Country-Level Market Analysis Across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa Competitive Benchmarking of Leading Vendors Linear Accelerator and Treatment Planning Software Portfolio Analysis VMAT, Sliding Window IMRT, Step-and-Shoot IMRT, and Tomotherapy Technology Analysis Application Analysis Across Prostate, Head and Neck, Lung, and Breast Cancer List of Figures Market Drivers, Challenges, Opportunities, and Restraints Regional Market Snapshot Competitive Landscape by Market Share Growth Strategies Adopted by Key Players Market Share by Technique, Product, Application, and End User (2025 vs. 2032) Global Intensity Modulated Radiotherapy Ecosystem and Value Chain Analysis Radiotherapy Equipment and Treatment Planning Technology Adoption Trends